Related Experiment Video

Updated: Jul 19, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Growth regulation via insulin-like growth factor binding protein-4 and -2 in association with mutant K-ras in lung

Hanako Sato1, Takuya Yazawa, Takehisa Suzuki

  • 1Department of Pathobiology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanagawa, Japan.

The American Journal of Pathology
|October 31, 2006
PubMed

Insights

Gain-of-function mutations in K-ras accelerate lung cell growth and induce insulin-like growth factor-binding proteins (IGFBP)-4 and IGFBP-2. This growth regulation is disrupted in lung cancer due to gene promoter hypermethylation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Gain-of-function mutations in K-ras are implicated in early pulmonary bronchioloalveolar carcinoma development.
  • K-Ras signaling pathways play a critical role in cell proliferation and differentiation.

Purpose of the Study:

  • To investigate the impact of K-Ras activation on mRNA expression in human peripheral lung epithelial cells.
  • To elucidate the mechanisms underlying IGFBP-4 and IGFBP-2 transcriptional activation in response to K-Ras signaling.
  • To understand the differences in IGFBP inducibility between non-neoplastic lung epithelia and lung carcinoma.

Main Methods:

  • Oligonucleotide microarrays were used to analyze altered mRNA expression.
  • Mutated K-ras was stably expressed in HPL1A cells and transduced into lung cancer cell lines.
  • Reporter assays and methylation analysis were employed to study gene promoter activity.

Main Results:

  • Mutated K-Ras expression accelerated cell growth and induced IGFBP-4 and IGFBP-2 in lung epithelial cells.
  • Egr-1 was identified as a crucial transcription factor for IGFBP-4/2 activation downstream of Ras-MAPK signaling.
  • Lung carcinoma cells exhibited weaker IGFBP-4/2 induction and often had hypermethylated IGFBP-4/2 promoters.

Conclusions:

  • Continuous K-Ras activation triggers a feedback system involving IGFBP-4/2 to regulate cell growth.
  • Disruption of this feedback mechanism, due to IGFBP-4/2 promoter hypermethylation, contributes to uncontrolled growth in lung cancer.
  • Targeting K-Ras signaling and epigenetic modifications may offer therapeutic strategies for lung cancer.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...